Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy for Stage I Malignant Pleural Mesothelioma

@article{Ruth2003CytoreductiveSC,
  title={Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy for Stage I Malignant Pleural Mesothelioma},
  author={Serge V Ruth and PhD P. Baas and PhD R. L. M. Haas and PhD E. J. Th. Rutgers and Victor J. Verwaal and PhD F. A. N. Zoetmulder},
  journal={Annals of Surgical Oncology},
  year={2003},
  volume={10},
  pages={176-182}
}
Background:Malignant pleural mesothelioma (MPM) is a disease mostly confined to the thoracic cavity. Untreated, the median survival is <1 year. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy is used to kill residual tumor cells on the surface of the thoracic cavity while having limited systemic side effects. Methods:From August 1998 to August 2001, 22 patients with stage I MPM were included in this study. Two patients were irresectable at operation… CONTINUE READING